Erratum {#Sec1}
=======

Unfortunately, after publication of this article \[[@CR1]\], it was noticed that the percentage of patients listed as RA positive was incorrect in two locations. In the 'Results' section of the abstract and in row 1, column 2 of Table [2](#Tab1){ref-type="table"}, the percentage was listed as 34.4%. The actual percentage should be 37.9%. The corrected 'Results' section of the abstract can be seen above and the corrected Table [2](#Tab1){ref-type="table"} can be seen below.Table 2Prevalence of anti-CarP, ACPA and RF in RA patients, disease controls and healthy subjectsDisease\
(No of patients)Anti-CarP positive n, (%)ACPA positive n, (%)RF positive n, (%)RA (309)117 (37.9)190 (61.4)202 (65.3)NHS (98)2 (2.04)1 (1.02)3 (3.06)SLE (83)14 (16.8)15 (18.07)19 (22.8)SS (45)14 (31.1)11 (24.4)23 (51.1)SSc (51)3 (5.8)1 (1.9)18 (35.2)OP (21)2 (9.5)2 (9.5)4 (19.04)*Anti-CarP* anti-carbamylated proteins antibodies, *ACPA* anti-citrullinated peptides antibodies, *RF* rheumatoid factor, *RA* Rheumatoid Arthritis, *NHS* Normal Healthy Subjects, *SLE* Systemic Lupus Erythematosus, *SS* Sjögren Syndrome, *SSc* Systemic Sclerosis, *OP* osteoporosis

The online version of the original article can be found under doi:10.1186/s13075-016-1173-0.
